Rehaler
Kongens Lyngby
About Rehaler
Rehaler is a biomedical company developing and commercializing novel treatments based on modulation of CO2 and oxygen in the central nervous system. Rehaler is a medtech company focused on the development, manufacturing, and commercialization of a novel, drug-free device for treating migraine with aura.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Last round: Grant (Jun 2023)
- Website: rehaler.io
- Phone: [email protected].
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/rehaler-2417950 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.